Mainstay Medical publishes 2017 full year results

- 15/02/2018

Dublin, Ireland: 15 February 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8, an implantable restorative neuro-stimulation system to treat disabling Chronic Low Back Pain, announces today the publication of its 2017 Full Year results and Annual Report.

More info on Mainstay Medical’s website.